NIH awards $2.4 million grant to UT Health San Antonio and ADA Science & Research Institute to study responsible antibiotic use

April 27, 2022

The National Institutes of Health has awarded a four-year, $2.4 million grant to The University of Texas Health Science Center at San Antonio (UT Health San Antonio), which will work in collaboration with the American Dental Association Science & Research Institute (ADASRI) to conduct a clinical trial studying the responsible use of antibiotics in combination with other treatments for periodontal disease, commonly known as gum disease.




In the race to solve Alzheimer’s disease, scientists find more needles in the haystack

April 20, 2022

Thanks to international collaboration, more genetic variations for Alzheimer’s disease are known today than ever before. The list of gene variants recognized for late-onset Alzheimer’s grew from one in 2009 to 40 in 2022. This month, scientists published a list of 75, some of which are considered as prime drug targets. Drug development is underway.




Team discovers novel drug target for Alzheimer’s and related dementias

April 14, 2022

Researchers from UT Health San Antonio today reported the discovery of a novel mechanism by which pathological forms of tau protein cause neurons to die. Alzheimer’s disease and chronic traumatic encephalopathy (CTE) are among more than 20 disorders that include tau protein pathology. The newly found mechanism of tau-induced damage can be altered pharmacologically, the scientists noted, making it a novel target for drug development.

Photo of a brain made of multicolored wires.




The Center for Mucosal & Microbiome Biology at UT Health San Antonio

April 5, 2022

UT Health San Antonio recently introduced its newest research center, the Center for Mucosal & Microbiome Biology, located within the Joe R. and Teresa Lozano Long School of Medicine. Led by Mansour M. Zadeh, PhD, distinguished professor of medicine in the Division of Gastroenterology and Nutrition, the center will function as a collaborative entity for […]